chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a certified medical assistant concerning a 38 year old female with high blood pressure, anemia, irritable bowel syndrome and anxiety who was vaccinated with a dose of measles virus vaccine live (Moraten) (lot number not available). Concomitant therapy included Maxzide, Atenolol, iron and Buspar. It was noted that on 03/25/1971 the patient was vaccinated with a dose of rubella virus vaccine live (HPV-77) MSD. Subsequently, a titer drawn on 07/02/04 revealed a negative result for measles, and was pending for rubella. Unspecified medical attention was sought. The outcome was unknown. Additional information has been requested.
Right after receiving the Janssen vaccine, patient got dizzy then she fainted for a few seconds. Patients was in the vaccination room with a technician and a pharmacist, reported she was getting better. She was fine and fully recovered after 30 minutes plus. She also stated that the reaction is just similar to what she got when she had other vaccines (she couldnot remember what it was)
This spontaneous report as received from a claims examiner refers to a patient of unknown age and gender. Medical history and drug allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX lot number reported as J003976, expiration date 28-JUN-2014 (concentration, dose and indication were not reported). Concomitant therapies were not reported. On an unknown date, the patient experienced an adverse reaction to ZOSTAVAX. The outcome of adverse reaction was unknown. Additional information has been requested. Lot number J003976 is an invalid lot number for ZOSTAVAX.
Patient received booster dose too soon. 2nd dose was given 12/15/21 and booster dose given 2/25/22
flublok inadvertently ordered, staff administered to patient. should have been fluzone with no reported adverse event; administration of flublok to patient younger than intended/ patient is 7 month infant and indication given as 18 years plus with no reported adverse event; Initial information received on 17-Jan-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 7 months old female patient and reporter sated that INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK] inadvertently ordered, staff administered to patient should have been INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE] with no reported adverse event and administration of flublok to patient younger than intended/ patient is 7 month infant and indication given as 18 years plus with no reported adverse event.   The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.  On 04-Jan-2023 the patient developed a non-serious event of flublok (dose: 0.5ml via intramuscular route, administration site and strength was unknown, batch number: UJ931AA and expiry date was unknown for prophylactic vaccination)inadvertently ordered, staff administered to patient. should have been fluzone with no reported adverse event (wrong product administered) (Latency: same day) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE and (INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE.  On 04-Jan-2023 the patient developed a non-serious event of administration of flublok to patient younger than intended/ patient is 7 month infant and indication given as 18 years plus with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE and INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE.  Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK) and INFLUENZA VACCINE TRIVALENT (FLUZONE) was not applicable.  Outcome: Unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 24-AUG-2015, the patient was vaccinated with an improperly stored dose of VAQTA (lot # L009445, exp. date: 01-JUN-2017) (strength, dose and route were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
shingles 24 days after 1st Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles 24 days after 1st Covid-19 vaccine) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced HERPES ZOSTER (shingles 24 days after 1st Covid-19 vaccine). At the time of the report, HERPES ZOSTER (shingles 24 days after 1st Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
I tested positive for COVID-19 on October 3, 2022 and I experienced a  headache, fever of 101.4; coughing, sneezing; fatigue; body aches;  really bad taste. I was prescribed Paxlovid and a cough suppressant and was told to take mucinex.
Patient's husband reports soreness and swelling at injection site, pain radiating to neck, and sore throat. Onset of symptoms on 9/29, 5 days after administration on 9/24.
pt recvd flu vax 1OCT93 & exp an unspecified react;
Achy for 3 days, ran a fever, and his arm hurt. After that he felt like his hands hurt, Claims his hands are swollen and that he now has arthritis from it
administered a Pediatric dose instead of an Adult dose; 22 YO patient administered a Pediatric dose; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 22-year-old female patient who received HBV (Engerix B pediatric) (batch number MY3RA, expiry date 21st September 2022) for prophylaxis.   On 23rd September 2021, the patient received the 1st dose of Engerix B pediatric. On 23rd September 2021, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.  Additional details were reported as follows: The patient was administered a Pediatric dose of Engerix B instead of an adult dose, which led to underdose and adult use of a child product. The reporter consented to follow-up.
Redness, itchy, warm to touch, , small welps over the lump just below injection site aprox. 1.5 in. in diameter.  Apply ice,  taking Benadryl for itching.   Just started today with the pronounced swelling and welps 2/5/2021, but had been a slight itchy feeling since getting injection on 1/29/2021 which is 7 days .
Patient was unknowing given the Moderna vaccine, age 1st dose given approx. 16 years of age. Submitting a VAERS report as this is a medication error as Moderna is only approved for 18 years and up.
Received vaccine 9-06-13 in PM. On 09-08-13 evening developed a rash with itching on both legs. Itching and rash still present 9-10-13. Client's mother states rash also in clients two brothers.
Fever, nausea, fatigue, pain at injection site.  Onset of fever 12 hours after administration of vaccine.   Fever still present 24 hours post onset of reaction.  Highest measured fever, 101.2 F.
One of five infants who experienced sterile abscess at the injection site (Deltoid) with tenderness.  Treatment included tylenol PRN.
Approximately three days after receiving the vaccine I started experiencing issues with my nervous system. At first, I was experiencing internal tremors. These mostly felt like strong vibrations (as if standing next to a washing machine in the spin cycle). Occasionally, it would feel more like waves (almost like lying on a water bed). Sometimes, the tremors were external as well, and others could see my hands trembling. The "spells" would last anywhere from several minutes to 8-10 hours and occurred almost daily for 5-6 weeks post-injection. My heart rate increased to 100 bpm for about 5 weeks. I would often wake up in the middle of the night with a racing heart (pumping hard, and I could hear my heartbeat in my ears). Some days the symptoms were so intense that it made it difficult to work. Besides the termors, I also felt twitching. Sometimes this was in the form of a muscle twitch (seeing my muscles moving involuntarily), but it also sometimes felt like "electric zaps" both in my chest and in my groin area. Two weeks after the injection, I also developed a large rash that spread over the entire left side of my torso. It was blotchy and felt "dry" but it did not hurt or itch. I noticed that I developed spider veins in this area as well. The rash cleared up after about 4-5 days.
PENTACEL was not available so CMA gave DTaP/IPV comno (labeled for 4-6 yrs) and separate Hib vaccines instead to a 2 month old patient.
inadvertedley administered adult dose to 7 year old; adult Engerix-B to 7 year old; This case was reported by a other health professional via call center representative and described the occurrence of accidental overdose in a 7-year-old male patient who received HBV (Engerix B adult) (batch number 7xy23, expiry date 29th April 2023) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th February 2022, the patient received Engerix B adult and Engerix B Pre-Filled Syringe Device. On 7th February 2022, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced accidental overdose and adult product administered to child. On an unknown date, the outcome of the accidental overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated that, on the day of reporting they inadvertedley administrated an adult dose of Engerix-B to the child patient, which led to accidental overdose and adult product administered to child. No further events were reported. The Vaccine administration facility was the same as Primary reporter. The reporter consented to follow up.
Pass out for only few minutes & recover, feel fine. Pt ask x anything w/ alcohol smell (alcohol pad, hand sanitizer) as mk her feel better. Also drank coke (mk her felt better). Felt dizzy but fine later at time leaving pharmacy.
12/4/12 Immunizations given 15 mo check up. 12/6/12 Office visit / mom stated fever 101-104 degrees since immunizations given. 12/7/12 Follow up visit Dx: Acute Pharyngitis / post vaccination.
Pain after injection that persisted for weeks & limited mobility that needed Dr.'s visit & Emergency Room. Patient was finally diagnosed with torn rotator cuff & given steroids. Pain is still there.
pt recv vax & devel an angry appearing red rash @ the inj site;pt was seen by MD  who dx cellulitis;
Pt c/o left arm swelling and pain, redness after receiving pneumonia vaccine one day pior. Pt took 2 (25 mg Benadryl) Full ROM in arm. Prescribed Augmentin and Prednisone. FU 24 hrs. Pt redness, pain, swelling all improved. Full ROM.
Multiple excursions that have occurred; Multiple excursions that have occurred; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Multiple excursions that have occurred) and POOR QUALITY PRODUCT ADMINISTERED (Multiple excursions that have occurred) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Multiple excursions that have occurred) and POOR QUALITY PRODUCT ADMINISTERED (Multiple excursions that have occurred). At the time of the report, PRODUCT STORAGE ERROR (Multiple excursions that have occurred) and POOR QUALITY PRODUCT ADMINISTERED (Multiple excursions that have occurred) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and Treatment medications was not specified
7 days after I got the shot, the skin at the vaccine administration site started itching. When I scratched it, some blisters burst and a big area on my arm swelled up. It was hot to the touch, visible as a red, raised circle about 5cm in diameter. The swollen area felt hard and itched intensely and hurt for several days. By 01/25/21, it had faded and by 01/26/21 the itching stopped.
This spontaneous report was received from a nurse referring to an unspecified number of patients of unknown age and gender. No medical history or concurrent conditions were provided. On an unspecified date, the patients were vaccinated with an improperly stored PROQUAD (Merck), (route of administration was not reported), (lot # K025761, expiry date 08-JUN-2016). At the time of this report, no adverse effects were reported. This is one of the several reports received from the same source. Additional information has been requested.
Chills, 100 degree temperature, down to 98.8 after 8 hours, sweating, muscle soreness
This spontaneous report was received from a physician refers to a multiple patients of unknown age and gender. No concurrent condition or medical history was reported. On an unknown date in January 2016, the patients were vaccinated with improperly stored dose (temperature: 33.7 F, time frame: 1 hour) of ROTATEQ (lot # L037921, exp. 31-MAY-2017, dose and route of administration not provided). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the several reports from same reporter link. Additional information has been requested.
Miscommunication at triage led to patient receiving a Moderna Covid-19 Vaccine after previously completing the Pfizer Covid-19 Vaccine series.  This meant that the patient recieved, in total, 3 Covid-19 Vaccinations.   The patient was truly there to recieve his 2nd Shingrix dose.
While waiting the required 15 minutes after being vaccinated the patient began to feel confused, had slowed speech, developed a globus sensation in her throat, as well as a pruritic rash on her chest and left arm.  EMS was called to bring patient to the ER; she was treated with Benadryl which immediately improved the globus sensation and significantly improved the rash. She was then dosed with solu-medrol as well. While at the hospital patient described a slight fullness of tongue and scratchiness of throat; the MD immediately treated with epinephrine and symptoms improved.  Patient was discharged in stable condition later the same night.
blood clots; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clots) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (blood clots) (seriousness criteria hospitalization and medically significant). At the time of the report, THROMBOSIS (blood clots) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Suspect product dosage text was reported as unknown.  It was reported that patient went into dialysis as a result of having blood clots from the vaccine. Company comment This spontaneous case concerns a patient of an unknown age and gender with no medical history reported, who experienced the unexpected, serious (medically significant and hospitalization), AESI of thrombosis and received a dose of mRNA-1273. The vaccination date and event onset date were not provided, thus, exact latency between vaccination and onset of the event could not be assessed. It was reported that patient went into dialysis as a result of having blood clots from the vaccine. No further clinical information was provided for review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact
At approximately 1050, pt received Johnson & Johnson booster vaccine, at approximately 1100 pt was in observation and c/o tongue swelling. Pt denies any difficulty breathing or swallowing, pt alert and did not appear in respiratory distress. Pt's past medical hx significant for anxiety and chronic enlarged tonsils. Np assessed and referred to EMS on site. EMS assessed and noted edema on left side of tongue and administered benadryl 25 mg PO, after monitoring repeat assessment revealed no change in symptoms and administered a second dose of benadryl 25 mg PO, pt monitored for 30-45 minutes, further evaluation indicated improved symptoms, when patient asked how does she feel patient states "my tongue feels fine and I feel back to normal." Patient then instructed to contact her son to pick her up from facility, pt educated on s/s of anaphylaxis and instructed to seek medical attention immediately if symptoms worsen. Pt left facility with a family member in stable condition.
Muscle and body aches that was the  first evening. The next morning, I had shortness of breath and headache. I felt like I had COVID all over again. I had COVID December 18, 2020. Weakness. Those symptoms lasted about three days. The hospital where I got the shot was where I was working. So they made me go in to be seen because of shortness of breath. They checked my Oxygen and listened to my lungs .End of February for a few weeks and again towards the end of March, I had cold/sinus infection symptoms for 3 or so weeks each time. Don't know if in between that time I was actually all  the way better but would feel a little better and then feel sick again.  And they gave me a Z-Pack and it didn't go away and so they gave me another  Z-Pack and it finally got better. Start of June, I had more cold/sinus infection symptoms. And that lasted a good 6 weeks. And by then it was my primary care doctor - Doxycycline is what they gave me for 10 days. I was on day 8 and  I wasn't getting any better so they had me stop taking it and so they put me on a 10 day cycle of 1000 mg twice a day of Amoxicillin and I finally got better. In an amongst all of that - the first time I was really sick. I am feeling better right now. Note: I had the second dose of vaccine on February 10, 2021.
On 8/9/2015 we noticed large, thick bruises on patient's legs.  On 8/11/2015 there was a bruise on the inside of his lower lip, small amount of blood while wiping after a bowel movement, petechiae around his eyes, and he experienced several nosebleeds lasting about 10 minutes. 8/13/2015 platelet count was done at the doctor's office with a result of 15,000.  Patient was diagnosed with idiopathic thrombocytopenic purpura (ITP) and admitted to the hospital, with additional platelet counts on 8/13/2015 and 8/14/2015 showing results from 19,000-20,000. On the evening of 8/14/2015 IVIG treatment was given. 8/15/2015 patient was discharged from the hospital with a platelet count of 63,000. 8/21/2015 platelet count was rechecked and was 323,000. Several counts have been done since, with results all above 150,000.  Patient has had no symptoms of ITP since treatment.
pt recvd vax;chest pain,SOB & leg cramping several hrs p/ 3rd dose;heavy sensation in arm 2hr p/;instructed to see MD at time but waited until next day because sxs not that bad;no cardiac or pulmonary disease found; pulmonary test all neg
First dose reaction::: Intense soreness in arm, running down arm and into fingers; shakiness/lightheadedness (almost like low blood sugar); body aches and joint pain; headache
On 12/28 I experienced Body aches and fatigue. On 12/29 I had body aches, fatigue and nausea. By 12/30 I had a 102 fever in addition to body aches, fatigue and nausea. On 12/31 I experienced vomiting and diarrhea in addition to body aches, fatigue and nausea, and fever. On 1/2/2022, I lost smell and taste, addition to body aches, fatigue and nausea, fever, vomiting and diarrhea. Colitis and Covid diagnosis at that time.
Pt returned to office about 1 hour post vaccination with c/o rash.  Very faint bumpy rash starting on arms, progressed through day to include trunk + legs. Mild itch.  Not hive-like.
Dad called today 9/24/10 at 3:30pm stating patient has been experiencing fever, headaches, nausea since this am. He has been giving her TYLENOL- it helps some.
Patient requested a shingles shot, received it, but had already completed the series in 2018
I noticed tinnitus approximately 1 week after the first shot. It was initially soft but became more noticeable as the weeks progressed. After the 2nd vaccine, it became more pronounced. It is bilateral, pulsatile. Initially I did not associate it with the vaccine and I am not sure if it is coincidental. Are there other reported cases?
Intense pain in my upper left arm near the injection site which woke me up at 4 AM after receiving the vaccine about 12 hours prior. Pain so intense I could not go back to sleep. Within an hour, the pain radiated down through my arm and spread through my entire body, resulting in very intensely uncomfortable aching, as if every cell in my body hurt, unlike anything I had experienced before. An hour later, I began to experience nausea, but that passed within an hour. Low fever. The whole-body aching has continued for nearly 12 hours now. Tylenol helped somewhat, but did not fully alleviate the very uncomfortable experience that made walking, typing on my computer, and even just lying still very uncomfortable, with occasional shooting pains.
Mom noticed, redness, warmth, swelling around the site. Child recieved four vaccines 2 in right thigh two in left thigh on 10/05/2011. Mom reported fever following vaccines (by touch). Pt reported pain and itching in area. Patient has large, 13 1/2 x 9cm,area of redness, swelling, warmth and pain. Diagnosis cellulitis. plan cold compress. tylonol. Keflex and septra given by rx.
hives, urticaria on chest and bilateral arms ; patient broke out in hives 15-20 mins after the injection